搜索优化
Rewards
English
搜索
Copilot
图片
视频
地图
资讯
购物
更多
航班
旅游
酒店
房地产
笔记本
Top stories
Sports
U.S.
Local
World
Science
Technology
Entertainment
Business
More
Politics
时间不限
过去 1 小时
过去 24 小时
过去 7 天
过去 30 天
按相关度排序
按时间排序
FiercePharma
1 小时
With Novo CEO on the hot seat at Senate hearing, PBMs and insurance concerns get the spotlight
When government officials and politicians scrutinize high U.S. drug prices, the role of insurers and pharmacy benefit ...
FiercePharma
3 小时
Ahead of adcomm, FDA challenges broad use of PD-1 drugs in stomach cancer patients
Besides stomach cancer, the FDA also raised a similar concern for PD-1 drugs in first-line esophageal squamous cell carcinoma ...
FiercePharma
7 小时
Bluebird bio lays off 25% of workforce as gene therapy pioneer struggles to stay afloat
After bluebird bio acknowledged troubles keeping its business operational, the gene therapy biotech is launching a ...
FiercePharma
5 小时
Currax, maker of weight loss drug Contrave, constructs campaign to educate on 'food noise'
Many people who struggle with weight management may experience an uncontrollable, near-obsessive preoccupation with food. | ...
FiercePharma
5 小时
Contract manufacturer PCI pumps $365M-plus into US, EU packaging projects
Flush with new business, Philadelphia-based CDMO PCI Pharma Services is blueprinting multiple manufacturing outlays on both ...
FiercePharma
7 小时
Regeneron's stock drops as it loses bid to block Amgen's Eylea biosimilar
Three months after a federal judge in West Virginia sided with Regeneron, blocking the market entry of two biosimilars for ...
FiercePharma
8 小时
Vertex taps Lonza to help produce global supply of cutting-edge CRISPR therapy Casgevy
With the launch of Casgevy gaining momentum, Vertex Pharmaceuticals is adding another link to its gene-editing therapy supply ...
FiercePharma
9 小时
Legend Biotech inks deal for 'priority access' to Multiply Labs' robotic cell therapy ...
After several years spent honing its robotic cell therapy manufacturing system, Multiply Labs has snared its first ...
FiercePharma
8 小时
Novo Nordisk CEO prepares to defend Ozempic, Wegovy US pricing at Senate hearing
After circling Novo Nordisk and its high GLP-1 drug prices for months, Sen. | Ahead of a hearing on Ozempic and Wegovy prices ...
FiercePharma
8 小时
Savara, eyeing rare disease drug submission next year, nabs Orchard's commercial lead to ...
Savara says it will in the first of half next year seek an FDA license to treat autoimmune pulmonary alveolar proteinosis ...
FiercePharma
9 小时
AGC Biologics telegraphs layoffs, winds down production operations at Colorado plant
As CDMOs across the industry continue to face pressure from a fluctuating biopharma business environment, AGC Biologics is ...
FiercePharma
10 小时
Docs discuss sluggish switch to Humira biosimilars, name preferred off-patent options
Spherix Global Insights has provided a different angle on AbbVie’s successful retention of Humira sales in the face of ...
当前正在显示可能无法访问的结果。
隐藏无法访问的结果
反馈